Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Collaborative Groups / G.I. and Other Associated Cancers Research Group / Discovered Vimentin methylation in stool and demonstrated in controlled reference sets a sensitivity of 84% at 85% specificity. In CLIA Lab.

Discovered Vimentin methylation in stool and demonstrated in controlled reference sets a sensitivity of 84% at 85% specificity. In CLIA Lab.

EDRN Founder Honored

Dr. Sudhir Srivastava was honored with the Distinguished Service Award from the American Pancreatic Association at the group's annual meeting this year, for his outstanding commitment to pancreatology.